Reasons may be: cancer patients were in the immunosuppressed status; the catalytic domain of carboxypeptidases was highly conserved among species, so human had partial immune tolerance to CPG2; CPG2 had a short t1/2 (24). Here, SYNE1 is linked to cancer.